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Retinal neuron degeneration and survival are often regulated by the same trophic factors that are required for embryonic
development and are usually expressed in multiple cell-types. Therefore, the conditional gene targeting approach is necessary
to investigate the cell-speciﬁc function of widely expressed and developmentally regulated genes in retinal degeneration. The
discussioninthisreview willbe focused onthe useofCre/lox-based conditionalgenetargeting approach inmechanisticstudies for
retinal degeneration. In addition to the basic experimental designs, this article addresses various factors inﬂuencing the outcomes
ofconditionalgene targetingstudies, limitationsofcurrent technologies,availabilityofCre-drive linesforvarious retinal cells,and
issues related to the generation of Cre-expressing mice. Finally, this review will update the current status on the use of Cre/lox-
based gene targeting approach in mechanistic studies for retinal degeneration, which includes rod photoreceptor survival under
photo-oxidative stress and protein traﬃcking in photoreceptors.
1.Introduction
The use of gene targeting with homologous recombination
in murine embryonic stem (ES) cells has led to many mecha-
nistic insights about human diseases. However, global gene
disruption has two major limitations that may prevent
the identiﬁcation of gene function in a target tissue or
in adults. First, disruption of essential genes often causes
embryonicorearlypostnatallethality[1].Second,disruption
of a ubiquitously expressed gene may not yield mechanistic
insights regarding the function of a protein of interest in
ap a r t i c u l a rc e l lt y p e[ 2, 3]. In these scenarios, temporal
or/and spatial gene disruption is far more advantageous.
The seminal work on the utilization of bacteriophage P1
site-speciﬁc recombination system in mammals by Dr. Brian
Sauer and his coworkers [4, 5] established a ﬁrm foundation
fortheCre/lox-basedgenetargeting,whichisthemostwidely
used conditional gene targeting approach to date.
Cre recombinase is a 38kDa protein and belongs to
the integrase family of recombinases [6]. Biochemically Cre
catalyzes site-speciﬁc DNA recombination, both intra- and
intermolecularly, between the 34 base pair loxP sites [7].
Cre carries a eukaryotic nuclear targeting sequence [8]a n d
is eﬃcient in performing site-speciﬁc DNA recombination
in mammals [9]. Therefore, Cre/lox system has become the
primary choice for the site-speciﬁc DNA recombination-
based manipulation of the mouse genome. Eﬃcient Cre-
mediated excision of DNA between directly repeated loxP
sites has been widely used in gene activation and deletion of
small or large segment of chromosomal DNA [9–11]. Cre-
mediated recombination also permits the translocation of
large DNA fragments on chromosomes [12] and integration2 Journal of Ophthalmology
(knock-in) or replacement of a gene or DNA segment
[13–15].Conditionalgeneknockoutisbyfar themostwidely
used application of Cre-mediated site-speciﬁc recombina-
tion [16]. The use of this strategy in retinal degeneration
studies will be the focus of this paper. In addition to
the general strategy of Cre/lox gene targeting, this review
will address various factors inﬂuencing the outcomes of
conditional gene targeting studies, limitations of current
technologies,availabilityofCre-drivelinesforvariousretinal
cells, and issues related to the generation of Cre-drive lines.
Finally, this paper will update the current status on the
use of Cre/lox-based gene targeting approach in mechanistic
studies for retinal degeneration, including the two most
advanced areas, rod photoreceptor survival under photo-
oxidative stress and protein traﬃcking in photoreceptors.
2.StrategyinExperimentalDesign
2.1. Basic Scheme of Experimental Design. Cre/lox condi-
tional gene targeting requires a mouse that has been pre-
engineered with a loxP-ﬂanked gene (or gene segment),
generated with homologous recombination in murine ES
cells (Figure 1). As the loxP sites are placed in introns, this
engineered mouse is phenotypically wild type. A conditional
gene knockout mouse is generated by breeding this mouse
with a mouse that expresses Cre under the control of a
tissue-speciﬁc promoter for two generations (Figure 1). In
the conditional gene knockout mouse, the loxP-ﬂanked gene
is removed in a tissue-speciﬁc fashion. Only cells/tissues
that express Cre carry the deleted gene, and thus they are
phenotypically mutants (Figure 1). In this way, one can
analyze the gene function in Cre-expressing tissues without
aﬀecting the gene expression in nontargeted tissues.
2.2. Considerations in Experimental Design. One concern
regarding the use of conditional gene targeting in vivo is
that the Cre-mediated excisive recombination is usually not
100 percent. Therefore, the eﬀect of gene disruption may
not be observed. It is important to understand that there
is a fundamental diﬀerence between Cre-mediated gene
disruption and conventional gene knockdown. As only four
Cre molecules are required for a productive Cre-mediated
recombination [7], Cre-mediated gene disruption occurs
usually in an all-or-none fashion in a particular cell. A most
likely scenario for a 20 percent eﬃciency of Cre-mediated
recombination is that approximately 20 percent of targeted
cells have 100 percent gene knockout. This is completely
diﬀerent from 20 percent gene knockdown in all cells. This
characteristic has made Cre/lox-based gene targeting a useful
approachingenefunctionanalysis, eventhoughitisrarethat
transgenic Cre mice express the recombinase in all targeted
cells/tissues. Since most gene function studies are targeting
the eﬀect of gene inside the cells, a fraction of targeted
cells with gene deletion could produce stable phenotypic
changes in animals [44, 45]. However, in a scenario that
no phenotypic change is observed in animals that have a
small portion of targeted cells carrying Cre-mediated gene
disruption, the interpretation of data needs to be cautious.
Another misconception in designing conditional gene
targeting studies is that a complete Cre-mediated excision
is more desirable. This is not always true, particularly, in
a situation that Cre may have toxic eﬀect to the cells or
phenotypic changes are too strong to be characterized. In a
previous study, we intentionally used a rod-expressing Cre
line with a lower eﬃciency of Cre-mediated recombination
to avoid unnecessary complication derived from potential
Cre toxicity in rods [44], as observed by others [21].
In a scenario that conditional gene targeting results in a
massive or/and rapid phenotypic change that hampers the
understanding of the biology and diseases, a lower level of
Cre expressionintargetedtissues/cells mayproduceagenetic
mosaic that attenuates the development of pathological
c h a n g e si na n i m a lm o d e l s[ 46].
3.Cre-Drive Lines
3.1. Available Cre-Drive Lines. Although Cre can be exoge-
nously delivered to a targeted tissue, it is usually expressed
under the control of tissue/cell speciﬁc promoters. A critical
factor for a successful conditional gene inactivation study
is the availability of a suitable Cre-expressing drive line.
Table 1 includesa list of published Cre-expressing drive lines
for various retinal cells. Since most retinal degeneration
studies are related to the photoreceptors and RPE, all pub-
lished rod-, cone-, and RPE-expressing Cre mouse lines are
listed in Table 1.R e t i n a lM¨ uller glia is the major supporting
cell and plays a critically role in maintaining structural and
functional integrity in the retina under stress conditions. As
most Cre-drive lines for M¨ uller glia were usually developed
for brain and Cre expression occurred outside ocular tissues
in these mice, Table 1 only lists a few that either have been
characterized more thoroughly or have been shown to be
successful in conditional gene targeting in the retina [3, 47,
48].Degenerationofretinalganglioncells(GCs)isbecoming
a focused research area for their role in glaucoma and for
the relevance to the safety of treating AMD patient with
anti-VEGF strategies [49]. A number of characterized GC-
expressing Cre-drive lines are thus listed in Table 1.W h i l e
inner nuclear layer (INL) neurons are not often investigated
for retinal degeneration, they are retinal neurons. The Cre-
drive lines for INL neurons can be used for studies related
to retinal neurobiology and are listed in Table 1.F i n a l l y ,C r e -
drive lines that are expressed in almost all retinal neurons
are also listed in Table 1. It is worth noting that some of the
listed Cre-expressing mouse lines were originally designed
to trace cell lineage and had strong developmental Cre
expression. These Cre lines may not be suitable for retinal
degeneration studies. Although some promoters employed
for Cre expression are useful in circumventing embryonic
lethality, due to their ubiquitous expression they cannot be
utilized to study a tissue/cell type-speciﬁc gene function.
3.2. Redundancy of Cre-Drive Lines. For most retinal cell-
types, Table 1 lists more than one Cre-drive line. It is impor-
tant to know that these seemly redundant Cre-drive lines are
necessary. As most published Cre-drive lines derived fromJournal of Ophthalmology 3
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Figure 1: Schematic diagram of generating a conditional knockout (CKO) mouse from breeding a tissue-speciﬁc Cre mouse (top right)
witha mousecarrying homozygousﬂoxed gene (top left).A CKO mouse carrying a homozygousﬂoxed gene and cre (either heterozygous or
homozygous) is obtained by genotyping the F2 oﬀspring. Tissue-speciﬁc Cre expression is shown as grey-eared (top right). Tissue-speciﬁc
gene KO is diagramed as black-eared (bottom).
the same or similar promoters are not identical, it is ideal
to have several usable Cre-drive lines for a particular cell-
typeduetothe following considerations. First, a rangeofCre
expression levels provide choice to achieve a suitable degree
of gene inactivation for a particular study. Second, variable
ecotopic expression patterns between the Cre-expressing
lines may produce unintended phenotypes that may be
beneﬁcial [24]. Third, transgenic cre is localized on one
of the 20 chromosomes in mice. There is a 5 percent of
possibility that cre may be residing on the same chromosome
where a loxP-ﬂanked gene is localized. Having more than
one Cre-drive line for a targeted tissue/cell-type is likely to
provideachoiceforthesuccessfulgenerationofaconditional
gene knockout mouse. Therefore, publishing a Cre-drive
line for a particular cell-type with already established drive
lines should be encouraged. Since there have not been many
side-by-side studies comparing diﬀerent Cre-drive lines as
performed by Ivanova et al. recently [31], it is not possible
to give an accurate account of the diﬀerences among Cre-
drive lines that target a particular cell-type. This review only
provides a roadmap about the available resources. To select
the most desirable Cre-drive line, end users should perform
side-by-side comparison, if necessary.
3.3. Types of Cre-Drive Lines. While the traditional trans-
genic approaches have proved to be useful for generating
Cre-drive lines, the inherent problems associated with this
approach [50] may cause variability in mutant phenotypes
among animals. This variability sometimes may result in
unintendedexpression patternthatmay ormaynot beuseful
for other studies [24]. The use of knock-in or bacterial
artiﬁcial chromosome based transgenic approaches is likely
to produce Cre-drive lines with the expression patterns that
more closely resemble the characteristics of the promoters.
In addition, the variability in Cre expression among animals
can be reduced using these transgenic approaches. For
these reasons, the Cre-drive lines referenced in Table 1 also
provide information on how these Cre-expressing mice were
generated. It is important to keep in mind that a Cre-drive
line generated with a knock-in approach may aﬀect the
expressionofthenativegeneandcarefulphenotypingofCre-
expressing mice are necessary.
Table 1 also includes information about whether Cre-
expressing lines are generated using an inducible promoter
system such as tetracycline- or tamoxifen-inducible systems
[51, 52]. While inducible tissue-/cell-speciﬁc gene knockout
approach is more advantageous, there are inherent problems
associated with these systems, such as leakiness [53, 54].
Eﬃcient delivery of inducing agents to the targeted retinal
cells at the peak of promoter activity is the key to the success
of inducible Cre expression. Although inducing gene expres-
sion in a tetracycline-inducible system with doxycycline for
a short period of time may not be harmful to the retina
[55], one should always keep in mind that tamoxifen may
be toxic to the retina [56]. One distinctive advantage of
using inducible systems is their ability to turn oﬀ/down the
expression of Cre, which may be toxic to the targeted cells
[19, 21].
3.4. Cre Toxicity. Cre is a DNA recombinase and may cause
unintended chromosomal rearrangement atcryptic sites [57,
58]. Proper control of Cre expression is required for Cre-
drive lines and a careful phenotypic analysis of Cre-drive
lines is a prerequisite for conditional gene targeting. How-
ever, the Cre toxicity may not be the only contributing factor
that caused retinal denegation in Cre-expressing rod-speciﬁc
C r em i c e[ 19, 21]. As expression of human rhodorpsin-
GFP fusion, a nontoxic protein, also caused progressive rod
photoreceptor degeneration [59], it is likely that a high level
of expression of an exogenous protein may be toxic to the4 Journal of Ophthalmology
Table 1: Published potentially useful Cre-drive lines in designing studies related to retinal degeneration.
Major targeted cells Minor/other expression Promoter References
Photoreceptors
M- and S-cone Not reported hRgp [17]
M-cone Not reported mMo [18]
S-cone Not reported mSo [18]
Rod Rod bipolar mRho [19]
Rod Not reported Irbp [20]
Rod Not reported hRho [21, 22]
RPE
∗RPE Optic nerve hVmd2 [23]
∗RPE M¨ uller cells/optic nerve/INL hVmd2 [24]
RPE Pigmented cells Dct [25]
RPE Neural retina Trp1 [26]
RPE Lens/neural retina Modiﬁed αA-crystallin [27]
M¨ uller glia
#M¨ uller cells GC and ONL Pdgfra [28]
∗M¨ uller cells INL hVmd2 [24, 29]
!#M¨ uller cells Brain Glast [30]
M¨ uller cells INL/Brain Thy1 [31, 32]
M¨ uller cells Brain Foxg1 [31]
Ganglion cells
GC Brain Grik4 [31]
Melanopsin-expressing GC Not reported Opn4 [33]
$GC Amacrine and horizontalcells Math5 [34]
GC/neural retina Brain Thy1.2 [35]
GC/Amacrine cells Brain Chat-(BAC transgenic) [31, 36]
Inner nuclear layer neurons
$Amacrine cells Not reported Chat-(knockin-JacksonLab) [31]
Bipolar cells photoreceptor/Brain Pcp2 [37]
#Rod bipolar cells Brain Pcp2 [38]
$Amacrine and horizontalcells Not reported Ptf1a [39]
Neural retina
#All retinal neurons Not reported Chx10 [40]
!All retinal neurons Brain PrP [41]
Neural retina Brian/multiple tissues Six3 [42]
#All retinal neurons Not reported Dkk3 [43]
∗Expression with a tetracycline-inducible approach. !Expression with a tamoxifen-inducible approach. #Expression with BAC transgenic approach.
$expression with knock-in approach. Abbreviations: Chat: choline acetyl transferase Dct: dopachrome tautomerase Dkk3: Dickkopf family protein 3 Foxg1:
Forkhead box G1, Glast: glutamate/aspartatetransporter, Grik4: glutamatereceptor, ionotropic kainate 4 precursor, hRgp: human red/green pigment,Math5:
murine atonal homolog 5, mRho: mouse rhodopsin, mMo:m o u s eM-opsin, mSo: Mouse S-opsin, Opn4:m e l a n o p s i n ,Pcp2:p u r k i n j ec e l lp r o t e i n2 ,Pdgfra:
platelet-derivedgrowth factor receptor-α, PrP: Prion protein, Ptf1a: pancreas speciﬁc transcriptionfactor 1a, Six3: six/sine oculis subclassof homeobox gene,
Thy1.2: Thymus cell antigen 1.2, and Trp1: tyrosinase-related protein.
host protein transcription/translation/maturation system in
rods.
3.5. New Cre-Drive Lines. For the past decade or so, many
laboratories have contributed considerable eﬀort in estab-
lishing various Cre-drive lines. While Cre-expressing mice
have been used successfully in conditional gene targeting,
there are not suﬃcient Cre-drive lines, even for the most
advanced ﬁeld, photoreceptor biology. Due to a high level of
Cre expression causes rod degeneration, it would be ideal to
have at least one inducible Cre-drive line for rods. As there
are at least ﬁfty types of retinal neurons, the current list
(Table 1) is far from completion. However, for most retinal
cell-types, a major shortcoming of most currently available
Cre-drive lines is a lack of temporal or spatial speciﬁcities
and desired eﬃciencies. Signiﬁcant improvement in this area
is needed. At present, a major challenge for Cre/lox-based
conditional gene targeting is the diﬃculties to obtain Cre-
drive lines with desired tissue-speciﬁcities. A lack of “ideal”
promoters is the major reason. Therefore, it is worthwhileJournal of Ophthalmology 5
to invest some eﬀort on studying the expression pattern of
potential promoters that drive Cre expression before making
am o u s e .
4.Dissecting CellularMechanisms of
RetinalDegeneration
4.1. Photoreceptor Survival under Photo-Oxidative Stress. A
majorfocusin retinal denegationistorevealthemechanisms
of photoreceptor survival. As many of the survival factors
are essential for development, global disruption of these
essential genes often causes embryonic lethality. Using
Cre/lox-based conditional gene targeting approach, Haruta
et al. demonstrated that Rac1, a component of NADPH
oxidase that produces reactive oxygen species, was required
for the rod photoreceptor protection from photo-oxidative
stress [60].Todeterminephotoreceptorsurvivalmechanisms
under photo-oxidative stress, Ueki et al. used rod-speciﬁc
gp130 knockout mice and showed that preconditioning of
mice with a sublethal photo-oxidative stress activated an
autonomous protective mechanism in rods through gp130,
an IL6 cytokine receptor, and, its downstream target STAT3
[61]. To determine further whether M¨ uller cells, major
retinal supporting cells often played a role in photoreceptor
protection by releasing survival factors, were involved in
this process, they demonstrated that gp130 activation in
M¨ uller cells had no additional eﬀect for rod survival under
photo-oxidative stress [47]. While this study demonstrates
the neuroprotective role of gp130-STAT3 pathway in the
rod photoreceptorsunderthechronic photo-oxidativestress,
another series of studies showed that the PI-3 kinase/AKT
pathway could protect rod photoreceptors under the acute
photo-oxidative stress. Using a conditional gene knockout
approach, Rajala et al. showed that insulin receptor, a PI-
3 kinase upstream regulator, had a protective eﬀect to
rod photoreceptors under the acute photo-oxidative stress
[62]. In another study using a conventional gene targeting
approach, disruption of AKT2, a PI-3 kinase downstream
target, accelerated the acute photo-oxidative stress-induced
rod photoreceptor degeneration [63]. Finally, Zheng et al.
demonstrated that BCL-xl, a downstream target of AKT,
was a rod survival factor under acute photo-oxidative stress
[44]. These studies clearly mapped the signiﬁcance of PI-
3 kinase/AKT pathway in stress-induced rod photoreceptor
survival in vivo.
4.2. Protein Traﬃcking and Photoreceptor Degeneration.
Kinesin-II is a molecular motor localized to the inner
segment, connecting cilium, and axoneme of mammalian
photoreceptors. The involvement of kinesin-II in protein
traﬃcking through the mammalian photoreceptor cilium
was initially probed with Cre/lox-based conditional gene
targeting. Loss of kinesin-II in rods caused signiﬁcant
accumulations of opsin, arrestin, and membrane proteins
within the photoreceptor inner segment, which ultimately
led to the death of photoreceptors, a phenotype that is
commonly observed in retinitis pigmentosa [20]. Further
experiments also suggested that ectopic accumulation of
opsin was a primary result of rod-speciﬁc kinesin-II deletion
[21]. Using a conditional gene targeting approach, Avasthi
et al. recently demonstrated that heterotrimeric kinesin-II
acted as a molecular motor for proper traﬃcking of mem-
brane proteins within the cone photoreceptors [64]. These
conditionalgenetargetingstudiesestablishedanunequivocal
role ofkinesin-II asa molecularmotorthat facilitatesprotein
membrane traﬃcking in the photoreceptors.
4.3. Conditional Gene Targeting in the RPE. RPE is the
gatekeeper of the retina and plays a pivotal role in the
maintenance of retinal neurons. Abnormal RPE function
is associated with both the wet and dry-forms of age-
related macular denegation (AMD) (for review see [65,
66]). Although the pathogenic mechanisms for dry-AMD is
unclear, clinical evidence suggests that photoreceptor degen-
eration is a consequence of impaired RPE functions [67, 68].
RPE-speciﬁc gene targeting will be a powerful approach
for functional analysis of the RPE-expressed genes in the
pathogenesis of dry-AMD. Whereas the use of conditional
gene targeting in the PRE is still at its infancy, investigating
the role of vascular endothelial growth factor (VEGF or
VEGF-A), a potent angiogenic factor whose polymorphisms
are associated with AMD [69, 70], in choroidal vascular
development has yield some information related to the
relationship between the RPE-derived VEGF and choroidal
vasculature [2, 71]. As abnormal choroidal vasculature is
clearly associated with both the dry- and wet-AMD [72–
75], the genetic systems established in these studies may have
some utility for AMD research. While the conditional gene
targeting approach has yet to reach its full potential in AMD
research, Lewin et al. recently demonstrated that disruption
ofmitochondrial manganese superoxidedismutase (SOD)in
the RPE produced a geographic atrophy-like phenotypes in
mice [76]. Here again, tissue/celltype-speciﬁc disruption of
widely expressed genes, such as VEGF and SOD,circumvents
the interference of nontargeting tissues/cells and is likely a
direction forgeneratinganimal modelsused formechanistic,
diagnostic, and therapeutic investigations in the years to
come.
5.ConcludingRemarks
Remarkable progress has been made since the publication of
the ﬁrst study on the retinal denegation using a conditional
gene targeting approach a decade ago [20]. It is also
important to realize that, except in protein traﬃcking and
photoreceptor survival, progress in other areas of retinal
biology is not keeping the pace. At present, cellular mecha-
nisms of many trophic factors and their signaling pathways
in the retina remains unclear. Although the RPE and M¨ uller
cells are two major retinal supporting cell-types, the post-
developmental functions of RPE and retinal M¨ uller cell-
derived trophic factors and their signaling mechanisms have
remained largely uninvestigated. Substantial eﬀort is neces-
sary to establish a framework for cellular mechanisms of
inherited retinal degeneration, AMD, and diabetes-induced
retinal neuron degeneration. Many of these investigations6 Journal of Ophthalmology
will require the use of conditional gene targeting approach.
With the improved Cre-drive lines and eﬀort in investigating
cell-speciﬁc function of trophic factors and their signaling,
signiﬁcant progress in our understanding of retinal degen-
eration will be achieved in the near future. Ultimately, these
ﬁndings will help to design therapeutic approaches for the
treatment of the retinal degenerative diseases.
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